
|Articles|May 1, 2007
Practice management in the era of anti-VEGF therapy (Part I)
Identifying the bottlenecks that are preventing effective management of neovascular AMD.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
















































